Press release

On 14 November 2006, Medscape Medical News reported that the European Commission approved on 8 November 2006 a gene-based test (PROGENSATM PCA3, made by Gen-Probe, Inc  and DiagnoCure, Inc) to aid in the diagnosis of prostate cancer.